Cargando…
Sublingual Immunotherapy for Japanese Cedar Pollinosis Attenuates Asthma Exacerbation
Autores principales: | Kikkawa, Sayaka, Nakagome, Kazuyuki, Kobayashi, Takehito, Soma, Tomoyuki, Kamijo, Atsushi, Nagata, Makoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439194/ https://www.ncbi.nlm.nih.gov/pubmed/30912332 http://dx.doi.org/10.4168/aair.2019.11.3.438 |
Ejemplares similares
-
Sublingual Immunotherapy for Japanese Cedar Pollinosis: Current Clinical and Research Status
por: Sakurai, Daiju, et al.
Publicado: (2022) -
Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis
por: Kurokawa, Tomoya, et al.
Publicado: (2022) -
Asthma in Patients With Japanese Cedar Pollinosis
por: Tanaka, Akihiko, et al.
Publicado: (2012) -
Japanese cedar pollen upregulates the effector functions of eosinophils
por: Miyauchi, Sachiko, et al.
Publicado: (2021) -
Complement Factor H Is an Early Predictive Biomarker of the Therapeutic Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis
por: Yoneda, Riyo, et al.
Publicado: (2022)